elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q24203661-405F5E60-662E-49E3-BB5A-F75C45DD9322
Q24203661-405F5E60-662E-49E3-BB5A-F75C45DD9322
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24203661-405F5E60-662E-49E3-BB5A-F75C45DD9322
Diuretics for heart failure
P2860
Q24203661-405F5E60-662E-49E3-BB5A-F75C45DD9322
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24203661-405F5E60-662E-49E3-BB5A-F75C45DD9322
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3640190dd67584917644ffb0a638f66267533527
P2860
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)